| |
| |
|
| Insider
Information: |
Shkreli Martin |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,765,168 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,826,626 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,765,168 |
|
|
| Total
Value |
$11,826,626 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Travere Therapeutics, Inc |
TVTX |
Fmr Officer Dir 10% Sh... |
2014-11-21 |
1,765,168 |
2012-12-12 |
0 |
Premium* |
|
|
Humanigen Inc |
HGEN |
10% Owner |
2016-08-26 |
0 |
2015-11-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2016-08-26 |
4 |
S |
$3.10 |
$960,141 |
D/D |
(309,723) |
0 |
0 |
- |
|
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2016-08-25 |
4 |
S |
$3.10 |
$5,930,939 |
D/D |
(1,913,206) |
309,723 |
0 |
- |
|
| HGEN |
Humanigen Inc |
Chief Executive Officer |
• • • |
2015-11-24 |
4 |
B |
$38.15 |
$190,750 |
D/D |
5,000 |
2,075,200 |
3.23 |
- |
|
| HGEN |
Humanigen Inc |
Chief Executive Officer |
• • • |
2015-11-20 |
4 |
B |
$18.88 |
$94,400 |
D/D |
5,000 |
2,070,200 |
3.23 |
- |
|
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2015-11-18 |
4 |
B |
$2.02 |
$888,800 |
D/D |
440,000 |
2,065,200 |
2.45 |
- |
|
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2015-11-17 |
4 |
B |
$1.93 |
$1,187,897 |
D/D |
613,677 |
1,625,200 |
2.45 |
- |
|
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2015-11-16 |
4 |
B |
$0.61 |
$444,198 |
D/D |
597,438 |
1,011,523 |
2.45 |
- |
|
| HGEN |
Humanigen Inc |
10% Owner |
– – • |
2015-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
414,085 |
|
- |
|
| TVTX |
Travere Therapeutics, Inc |
Fmr Officer Dir 10% Sharehldr |
– – – |
2014-11-21 |
4 |
S |
$8.41 |
$2,126,443 |
D/D |
(252,847) |
1,765,168 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Fmr Officer Dir 10% Sharehldr |
– – – |
2014-11-20 |
4 |
S |
$8.23 |
$1,105,989 |
D/D |
(134,354) |
2,018,015 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Fmr Officer Dir 10% Sharehldr |
– – – |
2014-11-19 |
4 |
S |
$8.54 |
$2,817,093 |
D/D |
(329,824) |
2,152,369 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Fmr Officer Dir 10% Sharehldr |
– – – |
2014-11-18 |
4 |
S |
$9.19 |
$2,343,501 |
D/D |
(254,975) |
2,482,193 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Fmr Officer Dir 10% Sharehldr |
– – – |
2014-11-17 |
4 |
S |
$9.41 |
$941,100 |
D/D |
(100,000) |
2,737,168 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Fmr Officer Dir 10% Sharehldr |
– – – |
2014-11-14 |
4 |
S |
$10.23 |
$1,022,790 |
D/D |
(100,000) |
2,837,168 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
332,980 |
2,995,148 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-10-01 |
4 |
B |
$8.11 |
$202,665 |
D/D |
25,000 |
2,962,168 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-10-01 |
4 |
S |
$0.01 |
$3,000 |
D/D |
(300,000) |
2,662,168 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-09-30 |
4 |
B |
$9.42 |
$37,680 |
D/D |
4,000 |
2,937,168 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-09-22 |
4 |
B |
$10.82 |
$378,707 |
D/D |
35,000 |
2,933,168 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-09-19 |
4 |
B |
$11.78 |
$212,035 |
D/D |
18,000 |
2,898,168 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-09-17 |
4 |
B |
$11.46 |
$68,740 |
D/D |
6,000 |
2,880,168 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-09-16 |
4 |
B |
$10.69 |
$80,190 |
D/D |
7,500 |
2,874,168 |
3.23 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-05-30 |
4 |
S |
$15.14 |
$4,426,936 |
D/D |
(292,400) |
2,866,668 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-05-30 |
4 |
A |
$14.62 |
$2,578,793 |
D/D |
176,388 |
3,159,068 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Chief Executive Officer |
• • • |
2014-04-04 |
4 |
B |
$19.64 |
$157,145 |
D/D |
8,000 |
2,982,680 |
3.23 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
